Posted on

Alzheimer’s drug lecanemab hailed as “breakthrough”

317966027 521855129966512 7850803736824252966 n

the staff of the Ridgewood blog

Ridgewood NJ, Lecanemab is the first drug to slow the destruction of the brain in Alzheimer’s. It attacks the beta amyloid that builds up in the brains of people with Alzheimer’s. Lecanemab only has a small effect and it only works in the early stages of the disease. Despite this, leading researchers are calling the findings ‘momentous’. Other therapies so far have had a 100% failure rate.

  20% off all web services with Spark Driven  

Leave a Reply

Your email address will not be published. Required fields are marked *